CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 92 filers reported holding CTI BIOPHARMA CORP in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $259,808 | +0.2% | 61,859 | +43.3% | 0.00% | – |
| Q4 2022 | $259,361 | +5.0% | 43,155 | +1.6% | 0.00% | – |
| Q3 2022 | $247,000 | -6.4% | 42,493 | -4.2% | 0.00% | – |
| Q2 2022 | $264,000 | – | 44,345 | +738983.3% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 6 | -100.0% | 0.00% | -100.0% |
| Q4 2021 | $2,407,000 | -15.9% | 970,435 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,863,000 | +18.0% | 970,435 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,426,000 | – | 970,435 | +16173816.7% | 0.00% | – |
| Q1 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 6 | -100.0% | 0.00% | – |
| Q2 2019 | $58,000 | -47.3% | 69,735 | -39.2% | 0.00% | – |
| Q1 2019 | $110,000 | -59.1% | 114,632 | -68.8% | 0.00% | – |
| Q4 2018 | $269,000 | -48.6% | 367,717 | +51.5% | 0.00% | – |
| Q3 2018 | $523,000 | -41.4% | 242,755 | +35.3% | 0.00% | – |
| Q2 2018 | $892,000 | +424.7% | 179,465 | +182.1% | 0.00% | – |
| Q4 2017 | $170,000 | -74.0% | 63,621 | -69.0% | 0.00% | – |
| Q3 2017 | $654,000 | – | 205,099 | +70623.8% | 0.00% | – |
| Q2 2017 | $0 | – | 290 | +1511.1% | 0.00% | – |
| Q1 2017 | $0 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|